TaiDoc Technology Corporation Share Price

Equities

4736

TW0004736004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
154 TWD -0.65% Intraday chart for TaiDoc Technology Corporation +0.98% -6.67%

Financials

Sales 2024 * 4.68B 144M 11.98B Sales 2025 * 4.95B 152M 12.67B Capitalization 14.69B 451M 37.62B
Net income 2024 * 997M 30.62M 2.55B Net income 2025 * 1.08B 33.27M 2.77B EV / Sales 2024 * 2.52 x
Net cash position 2024 * 2.91B 89.51M 7.46B Net cash position 2025 * 3.11B 95.43M 7.96B EV / Sales 2025 * 2.34 x
P/E ratio 2024 *
14.7 x
P/E ratio 2025 *
13.6 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 55.74%
More Fundamentals * Assessed data
Dynamic Chart
TaiDoc Technology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
TaiDoc Technology Corporation(TWSE:4736) added to Taiwan TAIEX Index CI
TaiDoc Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TaiDoc Technology Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
TaiDoc Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
TaiDoc Technology Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
TaiDoc Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
TaiDoc Technology Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
TaiDoc Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TaiDoc Technology Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
TaiDoc Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Taidoc Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Taidoc Technology Corporation Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Taidoc Technology Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Taidoc Technology Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day-0.65%
1 week+0.98%
Current month-0.65%
1 month-0.65%
3 months-5.52%
6 months+6.21%
Current year-6.67%
More quotes
1 week
152.50
Extreme 152.5
156.50
1 month
149.00
Extreme 149
156.50
Current year
149.00
Extreme 149
171.00
1 year
141.50
Extreme 141.5
189.50
3 years
141.50
Extreme 141.5
310.00
5 years
119.50
Extreme 119.5
310.00
10 years
56.87
Extreme 56.8707
310.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/08/01
Director of Finance/CFO - 01/11/01
Chief Tech/Sci/R&D Officer - 01/99/01
Members of the board TitleAgeSince
Chief Executive Officer - 01/08/01
Chief Tech/Sci/R&D Officer - 01/99/01
Director/Board Member - 01/10/01
More insiders
Date Price Change Volume
26/24/26 154 -0.65% 143,158
25/24/25 155 -0.32% 119,642
24/24/24 155.5 0.00% 131,740
23/24/23 155.5 +1.30% 119,086
22/24/22 153.5 +0.66% 95,271

End-of-day quote Taiwan S.E., April 26, 2024

More quotes
Taidoc Technology Corp is a Taiwan-based company mainly engaged in the manufacture and sale of medical equipment. The main products include diagnostic testing instruments and reagents, home medical instruments, professional medical monitoring equipment and telemedicine products. The diagnostic test instruments include blood glucose monitors and blood glucose test chips, blood glucose measurement systems, glycated hemoglobin meters. The home medical instruments include ear thermometers, electronic sphygmomanometers, nebulizers. The professional medical monitoring equipment include equipment for monitoring changes in physiological parameters such as blood glucose, blood pressure, blood oxygen concentration, electrocardiogram and body temperature in hospitals and clinics. The telemedicine products include medical products with network connection functions. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Middle East and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
154 TWD
Average target price
161 TWD
Spread / Average Target
+4.55%
Consensus